ロード中...
Anticoagulation in Patients with Ischaemic Heart Disease and Peripheral Arterial Disease: Clinical Implications of COMPASS Study
Patients with established cardiovascular disease may suffer further cardiovascular events, despite receiving optimal medical treatment. Although platelet inhibition plays a central role in the prevention of new events, the use of anticoagulant therapies to reduce events in atheromatous disease has,...
保存先:
| 出版年: | Eur Cardiol |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Radcliffe Cardiology
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6331781/ https://ncbi.nlm.nih.gov/pubmed/30697356 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15420/ecr.2018.12.2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|